Cargando…

The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections

OBJECTIVES: This study aimed to test the behavior of the case fatality rate (CFR) in a mixed population of vaccinated and unvaccinated individuals by illustrating the role of both the effectiveness of vaccines in preventing deaths and the detection of infections among both the vaccinated (breakthrou...

Descripción completa

Detalles Bibliográficos
Autores principales: di Lego, Vanessa, Sánchez-Romero, Miguel, Prskawetz, Alexia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983479/
https://www.ncbi.nlm.nih.gov/pubmed/35398301
http://dx.doi.org/10.1016/j.ijid.2022.03.059
_version_ 1784681984347340800
author di Lego, Vanessa
Sánchez-Romero, Miguel
Prskawetz, Alexia
author_facet di Lego, Vanessa
Sánchez-Romero, Miguel
Prskawetz, Alexia
author_sort di Lego, Vanessa
collection PubMed
description OBJECTIVES: This study aimed to test the behavior of the case fatality rate (CFR) in a mixed population of vaccinated and unvaccinated individuals by illustrating the role of both the effectiveness of vaccines in preventing deaths and the detection of infections among both the vaccinated (breakthrough infections) and unvaccinated individuals. METHODS: We simulated three hypothetical CFR scenarios that resulted from a different combination of vaccine effectiveness in preventing deaths and the efforts in detecting infections among both the vaccinated and unvaccinated individuals. RESULTS: In the presence of vaccines, the CFR depends not only on the effectiveness of vaccines in preventing deaths but also on the detection of breakthrough infections. As a result, a decline in the CFR may not imply that vaccines are effective in reducing deaths. Likewise, a constant CFR can still mean that vaccines are effective in reducing deaths. CONCLUSIONS: Unless vaccinated people are also tested for COVID-19 infection, the CFR loses its meaning in tracking the pandemic. This shows that unless efforts are directed at detecting breakthrough infections, it is hard to disentangle the effect of vaccines in reducing deaths from the probability of detecting infections on the CFR.
format Online
Article
Text
id pubmed-8983479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-89834792022-04-06 The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections di Lego, Vanessa Sánchez-Romero, Miguel Prskawetz, Alexia Int J Infect Dis Article OBJECTIVES: This study aimed to test the behavior of the case fatality rate (CFR) in a mixed population of vaccinated and unvaccinated individuals by illustrating the role of both the effectiveness of vaccines in preventing deaths and the detection of infections among both the vaccinated (breakthrough infections) and unvaccinated individuals. METHODS: We simulated three hypothetical CFR scenarios that resulted from a different combination of vaccine effectiveness in preventing deaths and the efforts in detecting infections among both the vaccinated and unvaccinated individuals. RESULTS: In the presence of vaccines, the CFR depends not only on the effectiveness of vaccines in preventing deaths but also on the detection of breakthrough infections. As a result, a decline in the CFR may not imply that vaccines are effective in reducing deaths. Likewise, a constant CFR can still mean that vaccines are effective in reducing deaths. CONCLUSIONS: Unless vaccinated people are also tested for COVID-19 infection, the CFR loses its meaning in tracking the pandemic. This shows that unless efforts are directed at detecting breakthrough infections, it is hard to disentangle the effect of vaccines in reducing deaths from the probability of detecting infections on the CFR. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-06 2022-04-06 /pmc/articles/PMC8983479/ /pubmed/35398301 http://dx.doi.org/10.1016/j.ijid.2022.03.059 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
di Lego, Vanessa
Sánchez-Romero, Miguel
Prskawetz, Alexia
The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections
title The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections
title_full The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections
title_fullStr The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections
title_full_unstemmed The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections
title_short The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections
title_sort impact of covid-19 vaccines on the case fatality rate: the importance of monitoring breakthrough infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983479/
https://www.ncbi.nlm.nih.gov/pubmed/35398301
http://dx.doi.org/10.1016/j.ijid.2022.03.059
work_keys_str_mv AT dilegovanessa theimpactofcovid19vaccinesonthecasefatalityratetheimportanceofmonitoringbreakthroughinfections
AT sanchezromeromiguel theimpactofcovid19vaccinesonthecasefatalityratetheimportanceofmonitoringbreakthroughinfections
AT prskawetzalexia theimpactofcovid19vaccinesonthecasefatalityratetheimportanceofmonitoringbreakthroughinfections
AT dilegovanessa impactofcovid19vaccinesonthecasefatalityratetheimportanceofmonitoringbreakthroughinfections
AT sanchezromeromiguel impactofcovid19vaccinesonthecasefatalityratetheimportanceofmonitoringbreakthroughinfections
AT prskawetzalexia impactofcovid19vaccinesonthecasefatalityratetheimportanceofmonitoringbreakthroughinfections